Purdue Pharma’s legal immunity deal, explained
The U.S. Supreme Court will rule on whether the Sackler family can proceed with a bankruptcy deal for Purdue Pharma, granting them full civil immunity from future opioid-related lawsuits in exchange for a 10-figure settlement. Andrew Chang breaks down the arguments for and against this deal and why almost all creditors are in favour.
![Purdue Pharma’s legal immunity deal, explained](https://thumbnails.cbc.ca/maven_legacy/thumbnails/627/10/Purdue_thumb_v6_no_banner_copy.jpg)
![](https://thumbnails.cbc.ca/maven_legacy/thumbnails/627/10/Purdue_thumb_v6_no_banner_copy.jpg)
The U.S. Supreme Court will rule on whether the Sackler family can proceed with a bankruptcy deal for Purdue Pharma, granting them full civil immunity from future opioid-related lawsuits in exchange for a 10-figure settlement. Andrew Chang breaks down the arguments for and against this deal and why almost all creditors are in favour.